Laboratoire M2

company

About

Laboratoire M2 manfactures innovative disinfection products from its proprietary platform named THYMOX TECHNOLOGY.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$4.60M
Industries
Health Care,Innovation Management,Logistics,Manufacturing
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Active

Laboratoire M2 manufactures innovative disinfection products from its proprietary platform named THYMOX TECHNOLOGY. Laboratoire M2 is also working on expanding its line of THYMOX TECHNOLOGY products and applications.the lab which has developed this technology branded as THYMOX.In order to ensure its exclusive ownership of the technology, Laboratoire M2 acquired the intellectual property rights to Thymox. The company holds Canadian and US and South-American patents on the product’s formulation and application, and has applied for patents in 40 other countries.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$4.60M
Laboratoire M2 has raised a total of $4.60M in funding over 2 rounds. Their latest funding was raised on May 8, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 8, 2017 Series B $4.60M 1 Desjardins-Innovatech Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Laboratoire M2 is funded by 1 investors. Desjardins-Innovatech are the most recent investors.
Investor Name Lead Investor Funding Round
Desjardins-Innovatech Yes Series B